Press Releases

 
Select:
Jun 14, 2021
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2021 and Provides Conference Call Information

Jun 08, 2021
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-End Financial Results on June 15, 2021

May 04, 2021
Elite Pharmaceuticals Enters into an Exclusive Distribution Agreement with Prasco, LLC and Announces Commercial Launch of Loxapine Capsules

Apr 29, 2021
Elite Pharmaceuticals, Inc. Names Marc Bregman as Chief Financial Officer

Feb 16, 2021
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2021 Ended December 31, 2020 and Provides Conference Call Information

Feb 10, 2021
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter of Fiscal Year 2021 Results on February 17, 2021

Jan 05, 2021
Elite Pharmaceuticals, Inc. Appoints Dr. Jason M. LePree as Vice President of Scientific Affairs

Nov 24, 2020
Elite Pharmaceuticals, Inc. Issues Statement on Product Approval Listing

Nov 16, 2020
Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter of Fiscal Year 2021 Ended September 30, 2020 and Provides Conference Call Information

Nov 11, 2020
Elite Pharmaceuticals, Inc. To Host Conference Call To Provide Corporate Update and Discuss Second Quarter of Fiscal Year 2021 Results on November 17, 2020

   1    2   3   4   5   6